EUVIMEDEUVIMED entdecken
Crossref

Clozapine's Molecular Signature: Selective 5‐ HT2A Receptor Downregulation and Signalling in Rat Brain Cortical Regions

Sylwia Kedracka-Krok iD, Jakub Nowak iD, Ewelina Fic iD, Joanna Solich iD, Piotr Rybczynski iD, Weronika Romanska iD, Patrycja Sarga iD, Katarzyna Pustelny iD, Marta Dziedzicka-Wasylewska iD

Journal of Neurochemistry · 2025

DOI: 10.1111/jnc.70229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, 2025. Verfasst von Sylwia Kedracka-Krok und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Biochemistry, Jagiellonian University, Faculty of Biochemistry, Biophysics and Biotechnology, Krakow, Poland. Hauptthemen laut MEDLINE: Clozapine, Receptor, Serotonin, 5-HT2A, Down-Regulation, Signal Transduction. Die Arbeit nennt 156 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The superior clinical efficacy of clozapine (CLO) in treatment‐resistant schizophrenia remains incompletely understood. To elucidate these mechanisms, we employed a multi‐platform proteomic strategy—combining data‐dependent acquisition (DDA) with fractionation, data‐independent acquisition (DIA) and targeted parallel reaction monitoring (PRM)—to analyse chronic drug‐induced proteomic changes in the prefrontal cortex (PFC) and remaining cerebral cortex (CX) of rats. This approach enabled unbiased analysis of over 6300 proteins per group in DDA and over 8700 in DIA. Consistent across all analytical methods, chronic CLO administration induced robust downregulation of the serotonin 5‐HT2A receptor (5HTR2A) in both PFC and CX, whereas risperidone (RIS) exhibited no significant effect on 5‐HTR2A levels at clinically relevant doses. Despite sharing high affinity for this receptor, CLO and RIS elicited markedly distinct signalling profiles. In the PFC, CLO inhibited serotonergic, G‐protein (Gαq and Gβγ), calcium, and cytoskeletal signalling pathways, accompanied by strong downregulation of phospholipase C delta 4 (PLCδ4), an isoform implicated in suicidal behaviour. Concurrently, CLO upregulated calcium‐independent phospholipase A2γ (iPLA2γ) and guanylyl cyclase C (GUCY2C), suggesting potential modulation of docosahexaenoic acid (DHA) signalling and cGMP‐driven synaptic plasticity. In contrast, RIS predominantly activated Gαi, Gαz, and Gβγ signalling in the CX and enhanced mitochondrial function. RIS also upregulated GUCY2C. Both drugs differentially modulated protein networks associated with potential heteromeric complexes involving 5HTR2As, including interactions with 5‐HT1A, 5‐HT2C, dopamine D2, oxytocin and cannabinoid CB1 receptors, highlighting their impact on complex serotonergic modulation. Notably, despite CLO's suppression of Gαq signalling, compensatory upregulation of Gαi was not observed, indicating a net attenuation of 5HTR2A‐mediated output rather than a simple G‐protein coupling switch. These findings advance our understanding of serotonergic, metabolic and receptor‐level adaptations induced by atypical antipsychotics and suggest that CLO's superior efficacy may derive from its unique ability to downregulate 5HTR2A and remodel signalling networks beyond classical dopaminergic mechanisms. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClozapineReceptor, Serotonin, 5-HT2ADown-RegulationSignal TransductionAntipsychotic AgentsCerebral CortexAnimalsRatsMaleRats, Sprague-DawleyProteomicsPrefrontal Cortex

Stichwörter der Autor:innen

DDADIAclozapineproteomicsrat cerebral cortexrat prefrontal cortexrisperidone5HTR2A

Substanzen

ClozapineReceptor, Serotonin, 5-HT2AAntipsychotic Agents

Autor:innen und Institutionen

  • Department of Physical Biochemistry, Jagiellonian University, Faculty of Biochemistry, Biophysics and Biotechnology, Krakow, Poland.
  • Jagiellonian University, Malopolskie Centrum Biotechnologii, Krakow, Poland.
  • Jerzy Maj Institute of Pharmacology Polish Academy of Sciences, Krakow, Poland.
  • Jagiellonian University, Doctoral School of Exact and Natural Sciences, Krakow, Poland.

ORCID-Profile: Sylwia Kedracka-Krok, Jakub Nowak, Ewelina Fic, Joanna Solich, Piotr Rybczynski, Weronika Romanska, Patrycja Sarga, Katarzyna Pustelny, Marta Dziedzicka-Wasylewska

Zitieren

APA

Kedracka-Krok, S., Nowak, J., Fic, E., Solich, J., Rybczynski, P., Romanska, W., Sarga, P., Pustelny, K., & Dziedzicka-Wasylewska, M. (2025). Clozapine's Molecular Signature: Selective 5‐ HT2A Receptor Downregulation and Signalling in Rat Brain Cortical Regions. Journal of Neurochemistry. https://doi.org/10.1111/jnc.70229

Vancouver

Kedracka-Krok S, Nowak J, Fic E, Solich J, Rybczynski P, Romanska W, et al. Clozapine's Molecular Signature: Selective 5‐ HT2A Receptor Downregulation and Signalling in Rat Brain Cortical Regions. Journal of Neurochemistry. 2025. doi:10.1111/jnc.70229

BibTeX
@article{KedrackaKrok2025,
  author = {Kedracka-Krok, Sylwia and Nowak, Jakub and Fic, Ewelina and Solich, Joanna and Rybczynski, Piotr and Romanska, Weronika and Sarga, Patrycja and Pustelny, Katarzyna and Dziedzicka-Wasylewska, Marta},
  title = {Clozapine's Molecular Signature: Selective 5‐ HT2A Receptor Downregulation and Signalling in Rat Brain Cortical Regions},
  journal = {Journal of Neurochemistry},
  year = {2025},
  doi = {10.1111/jnc.70229}
}
Kostenlos starten →